-
1
-
-
0029904791
-
Leukaemia during podophyllotoxin treatment in a patient with juvenile chronic arthritis
-
Kauppi M, Savolainen HA, Anttila VJ, et al. Leukaemia during podophyllotoxin treatment in a patient with juvenile chronic arthritis. Scand J Rheumatol 1996; 25 (5): 340
-
(1996)
Scand J Rheumatol
, vol.25
, Issue.5
, pp. 340
-
-
Kauppi, M.1
Savolainen, H.A.2
Anttila, V.J.3
-
2
-
-
0142069279
-
A 24 week clinical study of CPH 82/proresid/ placebo in rheumatoid arthritis
-
Jun
-
Lerndal T, Nilsson E, Gullberg R. A 24 week clinical study of CPH 82/proresid/ placebo in rheumatoid arthritis. Scand J Rheumatol 1990 Jun; 19 Suppl. 85: 47
-
(1990)
Scand J Rheumatol
, vol.19
, Issue.85 SUPPL.
, pp. 47
-
-
Lerndal, T.1
Nilsson, E.2
Gullberg, R.3
-
3
-
-
0142069279
-
A 24 week clinical study of CPH 82/proresid/ placebo in rheumatoid arthitis
-
Lerndal T, Gullberg R, Nilsson E. A 24 week clinical study of CPH 82/proresid/ placebo in rheumatoid arthitis. Scand J Rheumatol 1990; 19 (2): 172
-
(1990)
Scand J Rheumatol
, vol.19
, Issue.2
, pp. 172
-
-
Lerndal, T.1
Gullberg, R.2
Nilsson, E.3
-
4
-
-
0027203190
-
Interference with the cortisol axis by the microtubule antagonist, CPH82
-
Sep
-
Dahlqvist SR, Olsson T. Interference with the cortisol axis by the microtubule antagonist, CPH82. Br J Rheumatol 1993 Sep; 32 (9): 804-6
-
(1993)
Br J Rheumatol
, vol.32
, Issue.9
, pp. 804-806
-
-
Dahlqvist, S.R.1
Olsson, T.2
-
5
-
-
0027158135
-
Corticosteroid effect of CPH-82
-
Magnusson S. Corticosteroid effect of CPH-82. Scand J Rheumatol 1993; 22 (3): 136-7
-
(1993)
Scand J Rheumatol
, vol.22
, Issue.3
, pp. 136-137
-
-
Magnusson, S.1
-
6
-
-
0034032210
-
A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis
-
Oxford Mar
-
Lerndal T, Svensson B. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis. Rheumatology (Oxford) 2000 Mar; 39 (3): 316-20
-
(2000)
Rheumatology
, vol.39
, Issue.3
, pp. 316-320
-
-
Lerndal, T.1
Svensson, B.2
-
7
-
-
0034539290
-
CPH 82 (Reumacon®) in refractory inflammatory arthritis
-
Gudmundsdottir E, Jonsson H. CPH 82 (Reumacon®) in refractory inflammatory arthritis. Scand J Rheumatol 2000; 29 (5): 323-5
-
(2000)
Scand J Rheumatol
, vol.29
, Issue.5
, pp. 323-325
-
-
Gudmundsdottir, E.1
Jonsson, H.2
-
8
-
-
0037258334
-
Reumacon® (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis
-
Svensson B, Pettersson H. Reumacon® (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis. Scand J Rheumatol 2003; 32 (2): 83-8
-
(2003)
Scand J Rheumatol
, vol.32
, Issue.2
, pp. 83-88
-
-
Svensson, B.1
Pettersson, H.2
-
9
-
-
0142037339
-
CPH 82 versus azathioprine in the treatment of rheumatoid arthritis and reactive amyloidosis
-
Jun 6
-
Korpela M, Tiitinen S, Nissilä M. CPH 82 versus azathioprine in the treatment of rheumatoid arthritis and reactive amyloidosis. Ann Rheum Dis 1999 Jun 6; 213
-
(1999)
Ann Rheum Dis
, pp. 213
-
-
Korpela, M.1
Tiitinen, S.2
Nissilä, M.3
-
10
-
-
0142069277
-
Specific action on the cell cycle of the antirheumatic agent CPH82
-
Dahlqvist SR. Landberg G, Roos G. Specific action on the cell cycle of the antirheumatic agent CPH82. Scand J Rheumatol 1992; 21 (2): 101
-
(1992)
Scand J Rheumatol
, vol.21
, Issue.2
, pp. 101
-
-
Dahlqvist, S.R.1
Landberg, G.2
Roos, G.3
-
11
-
-
0002174567
-
Treatment of rheumatoid arthritis with Reumacon®. A placebo double-blind controlled study
-
Jun
-
Pettersson B, Hedin P-J. Treatment of rheumatoid arthritis with Reumacon®. A placebo double-blind controlled study. Scand J Rheumatol 1990 Jun: 19 Suppl. 85:48
-
(1990)
Scand J Rheumatol
, vol.19
, Issue.85 SUPPL.
, pp. 48
-
-
Pettersson, B.1
Hedin, P.-J.2
|